A cutting-edge imaging strategy could significantly improve survival rates among patients at risk for liver cancer.

Hepatitis C rates have surged in the U.S. as drug use and opioid abuse have risen. A Michigan Medicine hepatologist reflects on the troubling trend.

Rapid rise in liver deaths highlights new challenges in treatment and prevention despite gains in fighting hepatitis C, researchers say.

A new review of private insurance data finds that alcohol is a major contributor to cirrhosis cases — and that women drinkers are disproportionately af

A new review suggests it’s time to road test the point-of-care screening tools doctors use to identify brain dysfunction in patients with advanced liver disease.